Mangoceuticals, Inc. (MGRX) Balance Sheet
MGRX balance sheet, 2025
December 31, 2025 · U.S. dollars$16.1M assets = $890,568 liabilities + $15.2M equity
Both columns are drawn to the same scale: what MGRX owns equals what it owes plus shareholders’ equity. Hover a block for its value.
MGRX financial health
Descriptive bands, not a rating. Fiscal 2025.
MGRX balance sheet trends, 2021–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $22,5502021 | $16.1M2025 | +416.8%/yr | |
| Total liabilities | $39,2702021 | $890,5682025 | +118.2%/yr | |
| Shareholders’ equity | −$16,7202021 | $15.2M2025 | — | |
| Cash & short-term investments | $22,5502021 | $1.5M2025 | +184.9%/yr | |
| Total debt | $39,2702021 | $307,8232025 | +67.3%/yr | |
| Net cash (debt) | −$16,7202021 | $1.2M2025 | +$1.2M | |
| Working capital | −$16,7202021 | $656,8662025 | +$673,586 | |
| Current ratio | 0.572021 | 1.742025 | +1.16 | |
| Debt / equity | 0.572022 | 0.022025 | −0.55 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
MGRX assets
MGRX liabilities and equity
MGRX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
MGRX balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & short-term investments | $1.5M | $58,653 | $739,006 | $682,860 | $22,550 |
| Cash & equivalents | $1.5M | $58,653 | $739,006 | $682,860 | $22,550 |
| Receivables | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $18,501 | $0 | $0 |
| Other current assets | $61,096 | $16,942 | $60,953 | $11,745 | $0 |
| Total current assets | $1.5M | $75,595 | $818,460 | $694,605 | $22,550 |
| Property, plant & equipment (net) | $309,655 | $62,299 | $215,391 | $291,740 | $0 |
| Goodwill & intangible assets | $14.2M | $15.2M | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $16,942 | $16,942 | $0 |
| Total assets | $16.1M | $15.4M | $1.1M | $1.0M | $22,550 |
| Liabilities | |||||
| Accounts payable | $416,682 | $837,501 | $140,765 | $33,675 | — |
| Short-term debt | $307,823 | $214,962 | $63,718 | $224,185 | $39,270 |
| Total current liabilities | $890,568 | $1.4M | $211,078 | $260,577 | $39,270 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $307,823 | $64,962 | $128,679 | $185,405 | $0 |
| Other long-term liabilities | $0 | $0 | $64,961 | $128,680 | $0 |
| Total liabilities | $890,568 | $1.4M | $276,039 | $389,257 | $39,270 |
| Shareholders' equity | |||||
| Common stock & paid-in capital | $1,589 | $325 | $2,142 | $1,337 | $800 |
| Retained earnings (deficit) | −$40.6M | −$20.8M | −$11.2M | −$2.0M | −$17,701 |
| Accumulated other comprehensive income | −$2,760 | −$9,845 | — | $0 | $0 |
| Minority interest | −$1,542 | −$1,081 | $0 | — | — |
| Total shareholders' equity | $15.2M | $13.9M | $774,754 | $614,030 | −$16,720 |
| Key figures | |||||
| Total debt | $307,823 | $214,962 | $128,679 | $352,865 | $39,270 |
| Net cash (debt) | $1.2M | −$156,309 | $610,327 | $329,995 | −$16,720 |
| Working capital | $656,866 | −$1.3M | $607,382 | $434,028 | −$16,720 |
| Tangible book value | $968,063 | −$1.3M | $774,754 | $614,030 | −$16,720 |
| Book value per share | $1.51 | — | — | — | — |
| Shares outstanding | 10.1M | — | — | — | — |
| Current ratio | 1.74 | 0.05 | 3.88 | 2.67 | 0.57 |
| Quick ratio | 1.67 | 0.04 | 3.50 | 2.62 | 0.57 |
| Debt / equity | 0.02 | 0.02 | 0.17 | 0.57 | — |
| Equity / assets | 94.5% | 90.7% | 73.7% | 61.2% | −74.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $228,688 | $174,562 | $1.5M | $481,281 | $101,019 | $76,496 | $58,653 | $73,912 | $490,243 | $15,305 | $739,006 | $1.2M |
| Cash & equivalents | $228,688 | $174,562 | $1.5M | $481,281 | $101,019 | $76,496 | $58,653 | $73,912 | $490,243 | $15,305 | $739,006 | $1.2M |
| Receivables | $0 | $20,056 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $13,213 | $14,019 | $14,452 | $18,501 | $21,581 |
| Other current assets | $16,999 | $17,854 | $61,096 | $116,942 | $16,942 | $100,156 | $16,942 | $16,942 | $13,299 | $60,051 | $77,895 | $84,382 |
| Total current assets | $245,687 | $212,472 | $1.5M | $598,223 | $117,961 | $176,652 | $75,595 | $104,067 | $517,561 | $89,808 | $835,402 | $1.3M |
| Property, plant & equipment (net) | $280,538 | $295,605 | $309,655 | $13,260 | $29,974 | $46,330 | $62,299 | $77,974 | $213,143 | $194,697 | $215,391 | $235,853 |
| Goodwill & intangible assets | $13.6M | $13.9M | $14.2M | $15.9M | $20.7M | $21.5M | $15.2M | $14.6M | $14.6M | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $16,942 | $0 | $16,942 |
| Total assets | $14.2M | $14.4M | $16.1M | $16.5M | $20.8M | $21.8M | $15.4M | $14.8M | $15.2M | $301,447 | $1.1M | $1.6M |
| Liabilities | ||||||||||||
| Accounts payable | $889,733 | $529,800 | $416,682 | $526,964 | $767,996 | $1.2M | $837,501 | $753,962 | $718,650 | $1.1M | $140,765 | $89,059 |
| Short-term debt | $73,245 | $57,058 | — | $112,167 | $630,117 | $47,713 | $214,962 | $256,840 | $254,928 | $153,054 | — | $61,917 |
| Deferred revenue | $275,000 | — | — | — | — | — | — | — | — | — | — | −$89,059 |
| Total current liabilities | $1.4M | $737,606 | $890,568 | $804,275 | $1.6M | $1.5M | $1.4M | $1.4M | $1.4M | $1.2M | $211,078 | $159,176 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $279,207 | $294,023 | $307,823 | $12,167 | $30,117 | $47,713 | $64,962 | $81,507 | $97,545 | $113,267 | $128,679 | $143,425 |
| Other long-term liabilities | $250,906 | $236,965 | $0 | $0 | $0 | $0 | $0 | $12,167 | $30,118 | $47,712 | $64,961 | $81,508 |
| Total liabilities | $1.6M | $974,571 | $890,568 | $804,275 | $1.6M | $1.5M | $1.4M | $1.4M | $1.4M | $1.3M | $276,039 | $240,684 |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $1,803 | $1,698 | — | $1,389 | $1,065 | $715 | $325 | $213 | $2,913 | $2,362 | — | $1,679 |
| Retained earnings (deficit) | −$45.4M | −$44.1M | −$40.6M | −$37.9M | −$31.6M | −$25.9M | −$20.8M | −$18.0M | −$16.0M | −$13.6M | −$11.2M | −$8.7M |
| Accumulated other comprehensive income | −$5,198 | −$3,193 | — | −$2,079 | −$2,034 | −$2,221 | −$9,845 | −$1,663 | −$486,669 | −$70 | — | — |
| Minority interest | −$2,118 | −$1,533 | −$1,542 | −$1,739 | −$1,181 | — | — | — | — | — | — | — |
| Total shareholders' equity | $12.5M | $13.5M | $15.2M | $15.7M | $19.2M | $20.3M | $13.9M | $13.4M | $13.8M | −$958,432 | $774,754 | $1.4M |
| Key figures | ||||||||||||
| Total debt | $324,151 | $294,023 | — | $112,167 | $630,117 | $47,713 | $214,962 | $269,007 | $285,045 | $200,767 | — | $143,425 |
| Net cash (debt) | −$95,463 | −$119,461 | — | $369,114 | −$529,098 | $28,783 | −$156,309 | −$195,095 | $205,198 | −$185,462 | — | $1.1M |
| Working capital | −$1.2M | −$525,134 | $656,866 | −$206,052 | −$1.5M | −$1.3M | −$1.3M | −$1.3M | −$860,704 | −$1.1M | $624,324 | $1.2M |
| Tangible book value | −$1.1M | −$464,961 | $968,063 | −$191,053 | −$1.5M | −$1.3M | −$1.3M | −$1.2M | −$780,180 | −$958,432 | $774,754 | $1.4M |
| Book value per share | $0.73 | $0.82 | $0.96 | $1.36 | $1.93 | $4.41 | — | — | — | — | — | — |
| Shares outstanding | 17.1M | 16.5M | 15.9M | 11.5M | 10.0M | 4.6M | — | — | — | — | — | — |
| Current ratio | 0.18 | 0.29 | 1.74 | 0.74 | 0.07 | 0.12 | 0.05 | 0.07 | 0.38 | 0.07 | 3.96 | 8.44 |
| Quick ratio | 0.16 | 0.26 | 1.67 | 0.60 | 0.06 | 0.05 | 0.04 | 0.05 | 0.36 | 0.01 | 3.50 | 7.77 |
| Debt / equity | 0.03 | 0.02 | — | 0.01 | 0.03 | 0.00 | 0.02 | 0.02 | 0.02 | — | — | 0.11 |
| Equity / assets | 88.4% | 93.3% | 94.5% | 95.1% | 92.3% | 93.1% | 90.7% | 90.5% | 90.8% | −317.9% | 73.7% | 84.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed April 1, 2026); data from EODHD.
MGRX financial position
At the end of fiscal 2025 (December 31, 2025), Mangoceuticals had total assets of $16.1 million (up 4.7% from a year earlier), total liabilities of $0.9 million and shareholders' equity of $15.2 million. It held $1.5 million in cash and short-term investments against $0.3 million of debt, a net cash position of $1.2 million. Its current ratio was 1.74. In the latest quarter (ended June 30, 2026) total assets were $14.2 million and equity $12.5 million.
Related: MGRX income statement, MGRX cash flow statement, MGRX key metrics. See the MGRX stock overview for the latest quote and news.
MGRX balance sheet FAQ
What are Mangoceuticals's total assets?
Mangoceuticals reported total assets of $16.1 million at the end of fiscal 2025 (December 31, 2025), compared with $15.4 million a year earlier.
How much debt does Mangoceuticals have?
Mangoceuticals had $0.3 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.02.
How much cash does Mangoceuticals have?
Mangoceuticals held $1.5 million in cash and short-term investments at the end of fiscal 2025; with $0.3 million of debt that is net cash of $1.2 million.
What is Mangoceuticals's book value?
Mangoceuticals's shareholders' equity (book value) was $15.2 million at the end of fiscal 2025, or $1.51 per share.
What is Mangoceuticals's current ratio?
Mangoceuticals had current assets of $1.5 million and current liabilities of $0.9 million, a current ratio of 1.74 (it can cover its short-term obligations).
How much goodwill does Mangoceuticals have?
Mangoceuticals carried $14.2 million of goodwill and intangible assets, 88.5% of total assets, at the end of fiscal 2025.